Active Ingredient: BROMFENAC SODIUM
Proprietary Name: BROMFENAC SODIUM
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: EQ 0.09% ACID
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202030
Product Number: 001
Approval Date: Jan 9, 2013
Applicant Holder Full Name: AMRING PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
